Dr. Megan Coylewright is a structural interventional cardiologist whose clinical practice includes minimally invasive options to treat congestive heart failure (through valve repair and replacement, including TAVR and TEER) and prevent stroke (LAAO and PFO closure). She is a frequent lecturer on technical and procedural topics as well as the intersection of health policy and patient-centred shared decision-making and is known for her advocacy to broaden access to cardiovascular therapies in clinical trials for women and patients of colour. Dr. Coylewright serves leadership roles for device trials of aortic stenosis, left atrial appendage closure, and interatrial shunt therapies, among others. She is the co- principal investigator for one of the largest studies of heart teams. She completed her medical school, residency, and Master of Public Health training at Johns Hopkins and served as health disparities coordinator at the Baltimore City Public Health Department. Five years of cardiovascular training were spent at the Mayo Clinic in her home state of Minnesota.

Associate Professor Sonya Burgess is an Interventional Cardiologist, Consultant, and academic cardiologist. She is a SCAI Emerging Leader Fellowship Program recipient, with a PhD studying STEMI, incomplete revascularization, multi vessel disease, and multiple publications on women’s cardiovascular health and disparities, and the under-representation of women in cardiovascular workforces and research. She has over 100 peer reviewed publications including first author publications in NEJM, JACC, JAMA Cardiology and Circulation, the AHJ and IMJ, her research is cited in ESC 2023 guidelines. Dr Burgess is 1 of only 19 female interventional cardiologists in Australia and New Zealand, she chairs the CSANZ women in cardiology group.